Market Tracker

08/26 5:16pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

4.74
Delayed Data
As of Aug 26
 -0.03 / -0.63%
Today’s Change
4.62
Today|||52-Week Range
11.00
-40.00%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close4.77
Today’s open4.74
Day’s range4.62 - 4.88
Volume2,168,640
Average volume (3 months)1,826,906
Market cap$612.6M
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)+21.93%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.05+0.92%
RPTPRaptor Pharmaceutica...+0.25+3.56%
AIMTAimmune Therapeutics...+0.15+1.03%
DVAXDynavax Technologies...+0.17+1.06%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts